Is irritable bowel syndrome an inflammatory disorder?

Current Gastroenterology Reports

Volumn 10, Issue 4, 2008, Pages 385-390

  Giorgio, Roberto ^a   Barbara, Giovanni ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; IMMUNOGLOBULIN E;

ABDOMINAL PAIN; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; ESCHERICHIA COLI; FOOD ALLERGY; GASTROENTERITIS; GENETIC DISORDER; GENETIC RISK; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; INTESTINE MUCOSA; IRRITABLE COLON; LAMINA PROPRIA; MALABSORPTION; MAST CELL; MOLECULAR INTERACTION; MUCOSA INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALMONELLA; SENSORIMOTOR FUNCTION; SHIGELLA; STRESS; SYMPTOMATOLOGY; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; GASTROENTERITIS; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MAST CELLS;

EID: 52049123143     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0073-0     Document Type: Review

References (50)

1. Collins SM: The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996, 111: 1683-1699.
2. Barbara G, De Giorgio R, Stanghellini V, et al.: A role for inflammation in irritable bowel syndrome? Gut 2002, 51(Suppl 1): I41-i44.
3. Camilleri M: Management of the irritable bowel syndrome. Gastroenterology 2001, 120: 652-668.
4. De Giorgio R, Barbara G, Stanghellini V, et al.: Diagnosis and therapy of irritable bowel syndrome. Aliment Pharmacol Ther 2004, 20(Suppl 2): 10-22.
5. Longstreth GF, Hawkey CJ, Mayer EA, et al.: Characteristics of patients with irritable bowel syndrome recruited from three sources: Implications for clinical trials. Aliment Pharmacol Ther 2001, 15: 959-964.
6. Longstreth GF, Thompson GW, Chey WD, et al.: Functional bowel disorders. Gastroenterology 2006, 130: 1480-1491.
7. Barbara G, De Giorgio R, Stanghellini V, et al.: New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004, 20: 1-9.
8. Isgar B, Harman M, Kaye MD, Whorwell PJ: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983, 24: 190-192.
9. Spiller RC: Postinfectious irritable bowel syndrome. Gastroenterology 2003, 124: 1662-1671.
10. Barbara G, Vallance BA, Collins SM: Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997, 113: 1224-1232.
11. Barbara G, De Giorgio R, Deng Y, et al.: Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 2001, 120: 1729-1736.
12. Törnblom H, Lindberg G, Nyberg B, Veress B: Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002, 123: 1972-1979.
13. Spiller RC, Jenkins D, Thornley JP, et al.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47: 804-811.
14. Chadwick VS, Chen W, Shu D, et al.: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122: 1778-1783.
15. Dunlop SP, Jenkins D, Neal KR, et al.: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125: 1651-1659.
16. Dunlop SP, Jenkins D, Spiller RC: Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003, 98: 1578-1583.
17. Salzmann JL, Peltier-Koch F, Bloch F, et al.: Morphometric study of colonic biopsies: A new method of estimating inflammatory diseases. Lab Invest 1989, 60: 847-851.
18. Barbara G, Stanghellini V, De Giorgio R, et al.: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004, 126: 693-702.
19. O'sullivan M, Clayton N, Breslin NP, et al.: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000, 12: 449-457.
20. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38: 1590-1595.
21. Gwee KA, Leong YL, Graham C, et al.: The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999, 44: 400-406.
22. Wang LH, Fang XC, Pan GZ: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004, 53: 1096-1101.
23. Gwee KA, Collins SM, Read NW, et al.: Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52: 523-526.
24. Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132: 913-920.
25. Dinan TG, Quigley EM, Ahmed SM, et al.: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 2006, 130: 304-311.
26. Coelho AM, Fioramonti J, Bueno L: Systemic lipopolysaccharide influences rectal sensitivity in rats: Role of mast cells, cytokines, and vagus nerve. Am J Physiol 2000, 279: G781-G790.
27. Shah V, Lyford G, Gores G, Farrugia G: Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004, 126: 903-913.
28. Coutinho SV, Gebhart GF: A role for spinal nitric oxide in mediating visceral hyperalgesia in the rat. Gastroenterology 1999, 116: 1399-1408.
29. O'sullivan M, Clayton N, Moloney G, et al.: Increased iNOS expression in irritable bowel syndrome (IBS) patients with stress related symptoms [abstract]. Gastroenterology 2003, 124: A1642.
30. Hiatt RB, Katz L: Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 1962, 37: 541-545.
31. Barbara G, Wang B, Stanghellini V, et al.: Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132: 26-37.
32. Reed DE, Barajas-Lopez C, Cottrell G, et al.: Mast cell tryptase and proteinase-activated receptor 2 induce hyper-excitability of guinea-pig submucosal neurons. J Physiol 2003, 547: 531-542.
33. Gao C, Liu S, Hu HZ, et al.: Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 2002, 123: 1554-1564.
34. Nozdrachev AD, Akoev GN, Filippova LV, et al.: Changes in afferent impulse activity of small intestine mesenteric nerves in response to antigen challenge. Neuroscience 1999, 94: 1339-1342.
35. Bueno L, Fioramonti J, Delvaux M, Frexinos J: Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations. Gastroenterology 1997, 112: 1714-1743.
36. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M: Protease-activated receptors: Novel PARtners in innate immunity. Trends Immunol 2007, 28: 541-550.
37. Coelho AM, Vergnolle N, Guiard B, et al.: Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002, 122: 1035-1047.
38. Wood JD: Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 2004, 127: 635-657.
39. Cremon C, Gargano L, Morselli-Labate AM, et al.: Mucosal immune activation in irritable bowel syndrome is gender-dependent and associated with digestive symptoms [abstract]. Gastroenterology 2008, 134(Suppl 1): A690.
40. Schuurs AH, Verheul HA: Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990, 35: 157-172.
41. Chang L, Heitkemper MM: Gender differences in irritable bowel syndrome. Gastroenterology 2002, 123: 1686-1701.
42. Spiller RC, Campbell E: Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006, 22: 13-17.
43. Marshall JK, Thabane M, Borgaonkar MR, James C: Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007, 5: 457-460.
44. Spiller RC: Role of infection in irritable bowel syndrome. J Gastroenterol 2007, 42: 41-47.
45. Gonsalkorale WM, Perry C, Pravica V, et al.: Interleukin 10 genotypes in irritable bowel syndrome: Evidence for an inflammatory component? Gut 2003, 52: 91-93.
46. O'Mahony L, McCarthy J, Kelly P, et al.: Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128: 541-551.
47. Gonsalves N: Food allergies and eosinophilic gastrointestinal illness. Gastroenterol Clin North Am 2007, 36: 75-91.
48. Eutamene H, Theodorou V, Fioramonti J, Bueno L: Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J Physiol 2003, 553: 959-966.
49. Fukudo S, Nomura T, Hongo M: Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998, 42: 845-849.
50. Münch A, Ström M, Söderholm JD: Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies. Scand J Gastroenterol 2007, 42: 1167-1174.